This was the stock's second consecutive day of gains.

Abbott (NYSE:ABT) today unveiled a new feature within its FreeStyle Libre app for continuous glucose monitoring (CGM).

DexCom overview and recent share performance DexCom (DXCM) has drawn fresh attention as investors reassess its continuous glucose monitoring business and recent share performance, with the stock last ...

CES Tech Talk – Download and listen for the top trends expected at CES 2026. Exhibitor Examples: Aizip, AMD, DEEPX, LG Electronics, MAUM.AI, NXP Semiconductors, NVIDIA, PERCIVAI, Persona AI, Qualcomm, ...

The Nasdaq 100 (^NDX) is where investors find some of the most innovative and disruptive companies shaping the future. A ...

Now, it’s worth noting Stock Advisor’s total average return is 991 % — a market-crushing outperformance compared to 196% for ...

As the year comes to a close, it's time to look back at the numerous innovations across the diabetes technology industry in ...

Ulster come from behind to claim a fifth bonus-point win of their United Rugby Championship campaign against Connacht in ...

CONNACHT host Ulster at the Dexcom Stadium in the first of today’s URC inter-provincial derbies. Before Munster and Leinster ...

Significant changes at Johnson & Johnson were among the most-read medtech news on MassDevice over the past year.

Ulster centre Stuart McCloskey believes the side have "still got loads to work on" despite a largely strong start to their ...

Levi & Korsinsky, LLP notifies investors in DexCom, Inc. ("DexCom" or the "Company") (NASDAQ: DXCM) of a class action securities lawsuit.